Pharmacodynamic effects and immune correlates of response to the CD20/cd3 bispecific antibody mosunetuzumab in relapsed or refractory non-Hodgkin lymphoma Meeting Abstract


Authors: Hernandez, G.; Huw, L. Y.; Belousov, A.; Wilson, D.; Koeppen, H.; McCord, R.; Peng, K.; Bartlett, N. L.; Budde, L. E.; Assouline, S.; Nastoupil, L. J.; Yoon, D. H.; Matasar, M. J.; Bender, B.; Kwan, A.; Li, C. C.; O'Hear, C.; Yin, S.; Wei, M. C.; Adamkewicz, J. I.
Abstract Title: Pharmacodynamic effects and immune correlates of response to the CD20/cd3 bispecific antibody mosunetuzumab in relapsed or refractory non-Hodgkin lymphoma
Meeting Title: 61st Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 134
Issue: Suppl. 1
Meeting Dates: 2019 Dec 7-10
Meeting Location: Orlando, FL
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2019-11-13
Language: English
ACCESSION: WOS:000577160402137
DOI: 10.1182/blood-2019-123933
PROVIDER: wos
Notes: Meeting Abstract: 1585 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew J Matasar
    289 Matasar